NCAA Banned-Drug Classes 2008-09
The NCAA list of banned-drug classes is subject to change by
the NCAA Executive Committee. Contact NCAA education services
or the current list. The term “related
and related compounds
compounds” comprises substances that are included in the class by
their pharmacological action and/or chemical structure. No Other anabolic agents substance belonging to the prohibited class may be used, regardless of whether it is specifically listed as an example.
Many nutritional/dietary supplements contain NCAA banned
(c)Substances Banned for Specific Sports:
substances. In addition, the U.S. Food and Drug Administration
(FDA) does not strictly regulate the supplement industry; therefore
purity and safety of nutritional dietary supplements cannot be
guaranteed. Impure supplements may lead to a positive NCAA drug
test. The use of supplements is at the student-athlete’s own risk.
and related compounds
Student-athletes should contact their institution’s team physician or
athletic trainer for further information.
(d) Diuretics and other urine manipulators: Bylaw 31.2.3. Banned Drugs
The following is a list of banned-drug classes, with some examples of substances under each class. No substance belonging to the banned drug class may be used, regardless of whether it is specifically listed as an example. (a) Stimulants: and related compounds (e) Street Drugs: (f) Peptide Hormones and Analogues: (all the respective releasing factors of the above- mentioned substances also are banned.) and related compounds (g) Anti-Estrogens The following stimulants are not banned: (b) Anabolic Agents: and related compounds anabolic steroids (h) Definitions of positive depends on the following:
1for caffeine—if the concentration in urine exceeds 15
2for testosterone—if the administration of testosterone or use of
any other manipulation has the result of increasing the ratio of
the total concentration of testosterone to that of epitestosterone
in the urine to greater than 6:1, unless there is evidence that this
ratio is due to a physiological or pathological condition.
3for marijuana and THC—if the concentration in the urine of
22.214.171.124.1 Drugs and Procedures Subject to Restrictions. The use of the following drugs and/or procedures is subject to certain restrictions and may or may not be permissible, depending on limitations expressed in these guidelines and/or quantities of these substances used:
(Revised: 8/15/89) (a) Blood Doping. The practice of blood doping (the
intravenous injection of whole blood, packed red blood cells or blood substitutes) is prohibited, and any evidence confirming use will be cause for action consistent with that taken for a
positive drug test. (Revised: 8/15/89, 5/4/92) (b) Local Anesthetics. The Executive Committee will permit the limited use of local anesthetics under the following conditions: (1) That procaine, xylocaine, carbocaine or any other local anesthetic
may be used, but not cocaine; (Revised: 12/9/91, 5/6/93) (2) That only local or topical injections can be used (i.e., intravenous injections are not permitted); and
(3) That use is medically justified only when permitting the athlete to continue the competition without potential risk to his or her health.
(c)Manipulation of Urine Samples. The Executive Committee bans the use of substances and methods that alter the integrity and/or
validity of urine samples provided during NCAA drug testing. Examples of banned methods are catheterization, urine substitution and/or tampering or modification of renal excretion by the use of
diuretics, probenecid, bromantan or related compounds, and epitestosterone administration. (Revised: 8/15/89, 6/17/92, 7/22/97)
(d)Beta 2 Agonists. The use of beta 2 agonists is permitted by inhalation only. (Adopted: 8/13/93)
(e)Additional Analysis. Drug screening for select nonbanned
substances may be conducted for nonpunitive purposes. (Revised: 8/15/89)
Clinical Outcome Measures in Spinal Muscular Atrophy Jacqueline Montes, Andrew M. Gordon, Shree Pandya, Darryl C. De Vivo and Petra Kaufmann 2009; 24; 968 originally published online Jun 9, 2009; The online version of this article can be found at:http://jcn.sagepub.com/cgi/content/abstract/24/8/968 can be found at: Journal of Child Neurology Additional services and information f
Hepatotoxicity during therapy with Tipranavir, Citalopram and Finasterid – a case report C. Guhl¹, W. J. Heinz¹, R. Winzer¹, P. Langmann², H. Klinker¹ ¹ Department of Internal Medicine II, Division of Infectious Diseases, University of Würzburg, Germany² Private practice, Am Tiefen Weg, 97753 Karlstadt, Germany Background Other causes of elevated liver enzymes like alc